Financial Daily from THE HINDU group of publications
Thursday, Feb 10, 2005
News
Features
Stocks
Port Info
Archives
Google

Group Sites

 Corporate - Alliances & Joint Ventures


Grandix Pharma tie-ups

Our Bureau

KOCHI: Grandix Pharmaceuticals Ltd has fostered strategic tie-up with the UK-based Kareeb Chempharm and US company Neurosci Inc to tap the export potential and market its products in the US and European countries.

Grandix's core drug production realm is in the anti- diabetic, anti-hypertensive, neuropathy, anti-cholesterol and nutraceutical segments. Kareeb Chempharm will market Grandix's range of prescription drugs in the non-steroidal anti-inflammatory drugs segment in the UK and rest of Europe.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Vascular Concepts' stent undergoing clinical trials

Nicholas to invest $270 m in R&D
Vishal Exports Overseas' shares split to Re 1
IVRCL plans Rs 145-cr public issue
Gokuldas Exports plans public issue to fund expansion
Praj gets Bajaj Hindustan order
Tata Power to raise $200 m through FCCBs
Court grants stay on Easun Reyrolle EGM
Snecma to double manpower in India
Sun board clears merger of Phlox Pharma
Komal Chhabria `interested' in SWC's liquor biz
Career Launcher to expand base
VINS Bio embarks on expansion drive
Central Coalfields no more sick, says AAIFR
Tata AutoComp, UK's Stadco to set up joint venture
Lockheed Martin, HAL sign technical aid pact
Aprilia-Hero Motors jt venture called off
Grandix Pharma tie-ups
`Outlook for the next quarter is encouraging'
RMP Info aid for tsunami relief
BIFR okays revival scheme for S.S. Organics
Inter-ministerial group to examine prosecutions against Daewoo

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line